Teva Pharmaceutical (Germany) Investor Sentiment

TEV Stock  EUR 20.30  0.40  1.93%   
Roughly 62% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Teva Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Teva daily returns and investor perception about the current price of Teva Pharmaceutical Industries as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
Teva to Present Data Demonstrating UZEDY risperidone ... - BioSpace
Google News at Macroaxis
over a year ago at news.google.com         
Teva Launches New Pivot to Growth Strategy - Business Wire
Google News at Macroaxis
over a year ago at news.google.com         
Ciplas Advair Generic US Debut May Be Pushed Out But Value Intact - Scrip
Google News at Macroaxis
over a year ago at news.google.com         
MedinCell Announces the Successful Pricing of Its Global Offering ... - Business Wire
Google News at Macroaxis
over a year ago at news.google.com         
Teva Reports First Quarter 2023 Financial Results and Reaffirms ... - Business Wire
Google News at Macroaxis
over a year ago at news.google.com         
Global Synthetic Opioids Market Size 2023, Growth Prospects and ... - The Northwestern Examiner
Google News at Macroaxis
over a year ago at news.google.com         
MedinCell mdc-TJKs Phase 1 ... - Business Wire
Google News at Macroaxis
over a year ago at news.google.com         
First FDA Approval and US Commercial Launch, MedinCell Enters ... - Business Wire
Google News at Macroaxis
over a year ago at news.google.com         
Teva paid top executives 330m while share price tanked - Globes
Google News at Macroaxis
over a year ago at news.google.com         
Diffuse Large B-cell Lymphoma Market to Witness Upsurge in ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Monaco Asset Management SAM Sells 59000 Shares of Teva ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Sumitomo Mitsui Trust Holdings Inc. Decreases Holdings in Teva ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Nearly 35 percent to 40 percent of the Oxycodone Market is made up of the ... - Market Research Blog
Google News at Macroaxis
over a year ago at news.google.com         
Global Cellulitis Management Market is likely to witness humungous ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Strs Ohio Buys 561595 Shares of Teva Pharmaceutical Industries ... - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites